BNP Paribas Financial Markets
YARW

BNP Paribas Financial Markets’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

BNP Paribas Financial Markets’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2
Closed -$9.41K – 4295
2020
Q2 		$9.41K Sell
2
-2
-50% -$13.5K ﹤0.01% 3740
2020
Q1 		$43K Buy
4
+3
+300% +$47.1K ﹤0.01% 3618
2019
Q4 		$17.4K Hold
1
– – ﹤0.01% 4036
2019
Q3 		$8.61K Hold
1
– – ﹤0.01% 4182
2019
Q2 		$11.4K Hold
1
– – ﹤0.01% 4076
2019
Q1 		$16.5K Buy
+1
New +$24K ﹤0.01% 3948
2018
Q4 		– Hold
0
– – – 3843
2018
Q3 		– Hold
0
– – – 4257
2018
Q2 		– Hold
0
– – – 4258
2018
Q1 		– Hold
0
– – – 3630

Other funds holding YARW

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BNP Paribas Financial Markets's YARW Position: Q3 2020 in Review

BNP Paribas Financial Markets sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q3 2020, closing a stake of 2 shares — an estimated $9.41K sold.

BNP Paribas Financial Markets first reported a position in YARW in Q1 2019 and held it in 6 quarters. The position peaked at $43K in Q1 2020. 97 funds tracked by Wall St. Rank hold YARW as of Q3 2020.

  • BNP Paribas Financial Markets reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 2 Yarrow Bioscience, Inc. Common Stock shares in Q3 2020, an estimated $9.41K.
  • BNP Paribas Financial Markets first reported a position in Yarrow Bioscience, Inc. Common Stock in Q1 2019 and held it in 6 quarters.
  • BNP Paribas Financial Markets's Yarrow Bioscience, Inc. Common Stock position peaked at $43K in Q1 2020.
  • 97 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q3 2020.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2020, filed 30 Oct 2020.